ArticleCureus2026
The Use of MRI With Double-Dose Eovist for the Detection of Bile Leaks.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives Bile leaks are serious complications that can occur after liver transplant, hepatobiliary surgery, and abdominal trauma and can be challenging to diagnose. Noninvasive diagnostic studies for bile leaks are limited. In this study, we aimed to evaluate the efficacy of MRI with a double-dose of Eovist (gadoxetate disodium) in comparison with other imaging modalities for detecting biliary leaks. Methods This study involved a retrospective review of patients who underwent MRI with double-dose Eovist (dEovist) to evaluate suspected bile leakage from 2016 to 2022. Indications for evaluation included suspected bile leak after recent hepatobiliary surgery or penetrating right upper quadrant trauma. Once the dEovist study was performed and a bile leak was suspected, confirmation with endoscopic retrograde cholangiopancreatography (ERCP) was obtained. These results were statistically analyzed to determine the sensitivity and specificity of MRI with dEovist in detecting biliary leakage, and ERCP was used as the confirmatory test. Results A total of 19 patients were included. dEovist detected biliary leakage in five of 19 patients. All patients with concern for bile leak after MRI underwent ERCP for confirmation of the findings; four of these patients were confirmed as true positives, and one was determined to be a false positive. The remaining 14 patients with negative MRI findings with dEovist were followed clinically, and all had clinical courses that were not suggestive of bile leak. Six of these patients underwent ERCP, which also confirmed the absence of biliary leakage. The sensitivity of MRI with dEovist for detecting bile leaks in this study was 100% (95% confidence interval (CI): 39%, 100%), and the specificity was 93% (95% CI: 66%, 100%). Conclusions Prompt identification and early intervention are crucial for preventing the complications associated with bile leaks. The use of MRI with dEovist has shown promising results as a noninvasive imaging modality with high sensitivity and specificity in the detection of bile leaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.